Generic Name Alverine Alprazolam Atenolol Brompheniramine Bupropion Captopril Chlorthalidone Cimetidine Clorazepate Codeine Colchicine Diazepam Digoxin Dipyridamole Disopyramide Fentanyl Furosemide Fluvoxamine Haloperidol Hydralazine Hydrocortisone Isosorbide Loperamide Metoprolol Morphine Nifedipine Prednisone Quinidine Ranitidine Risperidone Theophylline Trazodone Triamterene Warfarin Complete References:
1. 2. Boustani MA, Campbell NL, Munger S, Maidment I, Fox GC. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311-20. Campbell N, Boustani M, Limbil T, Ott C, et al. The cognitive impact of anticholinergics: a clinical review. Clinical Interventions in Aging. 2009;4(1):225-33
Developed by the Aging Brain Program of the IU Center for Aging Research
Brand Name Spasmonal Xanax Tenormin Brovex, Lodrane, Lo-Hist Wellbutrin, Zyban Capoten Diuril, Hygroton Tagamet Tranxene Contin Colcrys Valium Lanoxin Persantine Norpace Duragesic, Actiq Lasix Luvox Haldol Apresoline Cortef, Cortaid Isordil, Ismo Immodium, others Lopressor, Toprol MS Contin, Avinza, Roxanol
Procardia, Adalat, Nifedical
Brand Name
Symmetrel Elavil Asendin Sal-Tropine Cogentin Dimetapp, Lodrane Tegretol Histex, Carbihist Chlor-Trimeton, Chlorphen Thorazine Tavist Anafranil Clozaril Flexeril Enablex Norpramin Bentyl Dramamine, others Benadryl, others Sinequan, Zonalon Urispas Atarax, Vistaril Anaspaz, Cystospaz, Levsin Tofranil Antivert, Bonine Demerol Robaxin Pamelor Zyprexa Norflex Trileptal Ditropan Paxil Trilafon Phenergan Pro-Banthine Seroquel Scopace, Transderm Scop Mellaril Detrol Stelazine Artane Surmontil
Deltasone, Sterapred Quinaglute Zantac Risperdal Theodur, Uniphyl Desyrel Dyrenium Coumadin
The following represents a list of alternative medications developed by an interdisciplinary group of specialists within the Aging Brain Program at Indiana University. These suggestions do not supersede clinical judgment, and are intended to assist clinicians in practicing in acute health care settings who provide care for patients with cognitive impairment such as dementia, mild cognitive impairment or delirium.
The following represents a list of alternative medications developed by an interdisciplinary group of specialists within the Aging Brain Program at Indiana University. These suggestions do not supersede clinical judgment, and are intended to assist clinicians in practicing in acute health care settings who provide care for patients with cognitive impairment such as dementia, mild cognitive impairment or delirium.
Recommended alternatives to medications with Definite Anticholinergic Properties Class ACB Drugs Alternatives Brompheniramine Carbinoxamine Allergies or itching: Chlorpheniramine Loratadine or Cetirizine orally First-Generation Clemastine Antihistamines Diphenhydramine Insomnia: Dimenhydrinate Trazadone orally Hydroxyzine
Recommended alternatives to medications with Definite Anticholinergic Properties Class ACB Drugs Alternatives Darifenacin Bladder Flavoxate Hold during acute care stay consider Antispasmodics Oxybutynin scheduling toileting Propantheline Tolterodine
Antidepressants
(Clinical judgment to consider if taper warranted) Depression: Sertraline or Citalopram orally Neuropathic pain: Gabapentin orally Insomnia: Trazadone orally
GI Antispasmodics
Antiemetics
Antipsychotics
(Recommendation does not apply to chronic use for psychiatric diagnosis) Acute care environment: Haloperidol orally or IM for 72 hours only
Cyclobenzaprine Methocarbamol
Analgesics
Meperidine
Central Anticholinergics
Seizures: Consult neurology for alternative Carbamazepine Neuropathic pain: Antiepileptics Oxcarbazepine Gabapentin or levetiracetam orally Mood disorders: Consult psychiatry for alternative For more information or permission to duplicate, please contact: Noll Campbell, PharmD or Malaz A. Boustani, MD, MPH Regenstrief Institute, Inc. 410 West 10th Street, Suite 2000 Indianapolis, IN 46202-3012 Phone: (317) 423-5633 Fax: (317) 423-5695 Email: rmanns@regenstrief.org